R. Sugerman

Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States

E. Brooks, J. Orange, M. Watson, 2015, Pediatrics.

Acquired protein S deficiency in children infected with human immunodeficiency virus.

J. Church, J. Goldsmith, R. Sugerman, 1996, The Pediatric infectious disease journal.

Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.

M. Goldberg, R. Wasserman, L. Mansfield, 2014, The journal of allergy and clinical immunology. In practice.

Office-based oral immunotherapy for food allergy is safe and effective.

R. Wasserman, L. Mansfield, R. Sugerman, 2011, The Journal of allergy and clinical immunology.

Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled study.

C. Crim, C. Scott, R. Mehta, 2006, The Journal of pediatrics.

Real-World Experience with Peanut Oral Immunotherapy: Lessons Learned From 270 Patients.

R. Wasserman, M. Herbert, S. Silvers, 2019, The journal of allergy and clinical immunology. In practice.

Fluticasone propionate HFA improves asthma control in pre-school age children with asthma

C. Crim, C. Scott, A. Teper, 2005 .

Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States.

M. Watson, L. Notarangelo, J. Walter, 2014, JAMA.

Oral Immunotherapy (OIT) of Food Allergy (FA) Successfully Desensitizes Most Patients

R. Wasserman, R. Sugerman, A. Gallucci, 2011 .